Wolf A - Search Results

1

Viability of Primary Human Pigment Epithelium Cells and Muller-Glia Cells after Intravitreal Ziv-Aflibercept and Aflibercept.

Costa de Andrade G, Wertheimer C, Eibl K, Wolf A, Kampik A, Buchele Rodrigues E, Farah ME, Haritoglou C. Costa de Andrade G, et al. Among authors: wolf a. Ophthalmologica. 2016;236(4):223-227. doi: 10.1159/000452677. Epub 2016 Dec 21. Ophthalmologica. 2016. PMID: 27997919

2

Optical coherence tomography for the detection of laser in situ keratomileusis in donor corneas.

Priglinger SG, Neubauer AS, May CA, Alge CS, Wolf AH, Mueller A, Ludwig K, Kampik A, Welge-Luessen U. Priglinger SG, et al. Among authors: wolf ah. Cornea. 2003 Jan;22(1):46-50. doi: 10.1097/00003226-200301000-00011. Cornea. 2003. PMID: 12502948

3

Absence of scar formation in human donor cornea with prior laser in situ keratomileusis.

Priglinger SG, May CA, Alge CS, Wolf A, Neubauer AS, Kampik A, Welge-Luessen U. Priglinger SG, et al. Among authors: wolf a. J Cataract Refract Surg. 2005 Jul;31(7):1403-8. doi: 10.1016/j.jcrs.2004.12.054. J Cataract Refract Surg. 2005. PMID: 16105614

4

Immunohistochemical findings after LASIK confirm in vitro LASIK model.

Priglinger SG, May CA, Alge CS, Wolf A, Neubauer AS, Haritoglou C, Kampik A, Welge-Lussen U. Priglinger SG, et al. Among authors: wolf a. Cornea. 2006 Apr;25(3):331-5. doi: 10.1097/01.ico.0000183535.99651.7b. Cornea. 2006. PMID: 16633035

5

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A. Haritoglou C, et al. Among authors: wolf a. Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf. Retina. 2006. PMID: 17151486 Clinical Trial.

6

Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study.

Reiniger IW, Wolf A, Welge-Lüssen U, Mueller AJ, Kampik A, Schaller UC. Reiniger IW, et al. Among authors: wolf a. Am J Ophthalmol. 2007 Apr;143(4):705-7. doi: 10.1016/j.ajo.2006.11.040. Epub 2006 Dec 21. Am J Ophthalmol. 2007. PMID: 17386288

7

Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.

Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A. Priglinger SG, et al. Among authors: wolf ah. Retina. 2007 Oct;27(8):1004-12. doi: 10.1097/IAE.0b013e3180ed458d. Retina. 2007. PMID: 18040236 Clinical Trial.

8

The protective effect of quercetin against oxidative stress in the human RPE in vitro.

Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A, Welge-Lüssen UC. Kook D, et al. Among authors: wolf ah. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1712-20. doi: 10.1167/iovs.07-0477. Invest Ophthalmol Vis Sci. 2008. PMID: 18385095

9

Ocular manifestation of primary VZV infection in a splenectomized patient.

Wolf AH, Thurau SR, Kook D, Haritoglou C. Wolf AH, et al. Ocul Immunol Inflamm. 2008 Jul-Aug;16(4):199-201. doi: 10.1080/09273940802233971. Ocul Immunol Inflamm. 2008. PMID: 18716958

10

Bacterial contamination of needle points after intravitreal injection.

Nentwich M, Yactayo-Miranda Y, Weimann S, Froehlich S, Wolf A, Kampik A, Mino De Kaspar H. Nentwich M, et al. Among authors: wolf a. Eur J Ophthalmol. 2009 Mar-Apr;19(2):268-72. doi: 10.1177/112067210901900215. Eur J Ophthalmol. 2009. PMID: 19253245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,363 results

Search Page

Filters